Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors.

Nasopharyngeal Carcinoma Salvage Therapy Surgical Procedures, Endoscopic

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
02 Oct 2024
Historique:
received: 25 06 2024
revised: 28 08 2024
accepted: 21 09 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 3 10 2024
Statut: aheadofprint

Résumé

This systematic review evaluates the efficacy and morbidity of transnasal endoscopic nasopharyngectomy as a salvage treatment for advanced-stage recurrent nasopharyngeal carcinoma (rNPC). Following PRISMA guidelines, we conducted a systematic search in Medline, Scopus, and PubMed, identifying studies on transnasal endoscopic nasopharyngectomy for rNPC. Inclusion criteria encompassed histologically confirmed rT3 and rT4 NPC patients previously treated with radiotherapy or chemoradiotherapy. Data on overall survival (OS), disease-free survival (DFS), and complications were extracted and analyzed. Nine studies, including a total of 429 patients, met the inclusion criteria. Five studies reported 2-year overall survival (OS) rates ranging from 34.6 % to 88.7 %. Three studies reported 3-year OS rates between 50 % and 63.5 %. Long-term 5-year survival varied widely from 0 % to 100 % across three studies. One study detailed 1-year disease-free survival (DFS) and OS at 93 % and 98 %, respectively. The pooled analysis included 429 patients with a median follow-up of 26.1 months. Complications were predominantly minor and transient. Major complications included necrosis, hemorrhage, cranial nerve palsy, and death. Advanced surgical techniques and pre-treatment measures, such as internal carotid artery embolization, improved resection outcomes and reduced complication rates. Transnasal endoscopic nasopharyngectomy emerges as a viable salvage option for advanced rNPC, offering favorable survival outcomes and manageable complication profiles. Future research should focus on refining surgical techniques and improving patient selection criteria to further enhance treatment efficacy.

Identifiants

pubmed: 39362026
pii: S1368-8375(24)00366-X
doi: 10.1016/j.oraloncology.2024.107048
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107048

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Gulpembe Bozkurt (G)

University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital, Istanbul, Turkiye.

Mario Turri Zanoni (M)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Lariana, Como, Italy.

Marco Ferrari (M)

Section of Otorhinolaryngology Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy.

Alessandro Ioppi (A)

Department of Otorhinolaryngology-Head and Neck Surgery, "S. Chiara" Hospital, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.

Sinem Kara Peker (S)

University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-In-Furness, England, the United Kingdom of Great Britain and Northern Ireland.

Hasan Elhassan (H)

ENT Department, Homerton University Hospital, London, the United Kingdom of Great Britain and Northern Ireland.

Melis Ece Arkan Anarat (M)

University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-In-Furness, England, the United Kingdom of Great Britain and Northern Ireland.

Yetkin Zeki Yilmaz (Y)

Istanbul University - Cerrahpasa, Cerrahpasa Medical Faculty, Department of Otorhinolaryngology, Istanbul, Turkiye.

Stefano Taboni (S)

Section of Otorhinolaryngology Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy.

Alessandra Ruaro (A)

Section of Otorhinolaryngology Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy.

Vittorio Rampinelli (V)

Unit of Otorhinolaryngology Head and Neck Surgery, ASST Spedali Civili Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Davide Mattavelli (D)

Unit of Otorhinolaryngology Head and Neck Surgery, ASST Spedali Civili Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Alberto Schreiber (A)

Unit of Otorhinolaryngology Head and Neck Surgery, ASST Spedali Civili Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Alessandro Vinciguerra (A)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.

Benjamin Verillaud (B)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.

Paolo Battaglia (P)

Department of Otorhinolaryngology, Circolo Hospital and Macchi Foundation, University of Insubria, Varese, Italy.

Cesare Piazza (C)

Unit of Otorhinolaryngology Head and Neck Surgery, ASST Spedali Civili Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Philippe Herman (P)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.

Paolo Castelnuovo (P)

Department of Otorhinolaryngology, Circolo Hospital and Macchi Foundation, University of Insubria, Varese, Italy.

Piero Nicolai (P)

Section of Otorhinolaryngology Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy.

Alperen Vural (A)

Istanbul University - Cerrahpasa, Cerrahpasa Medical Faculty, Department of Otorhinolaryngology, Istanbul, Turkiye. Electronic address: alperen.vural@iuc.edu.tr.

Classifications MeSH